Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
28 studies found for:    Marfan Syndrome
Show Display Options
RSS Create an RSS feed from your search for:
Marfan Syndrome
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Atenolol Versus Losartan in the Prevention of Progressive Dilation of the Aorta in Marfan Syndrome
Condition: Marfan Syndrome
Interventions: Drug: Losartan;   Drug: Atenolol
2 Recruiting Aortopathy in Persons With Bicuspid Aortic Valve, Turner and Marfan Syndrome
Conditions: Turner Syndrome;   Bicuspid Aortic Valve;   Marfan Syndrome
Intervention:
3 Recruiting Development of a Blood Test for Marfan Syndrome
Conditions: Marfan Syndrome;   Marfan Related Disorders;   Control Subjects
Intervention:
4 Completed Clinical Variability in Marfan Syndrome
Condition: Marfan Syndrome
Interventions: Procedure: skin punch biopsy and molecular biology;   Other: fibroblast culture and molecular biology
5 Completed Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome
Condition: Marfan Syndrome
Intervention: Drug: Coversyl (perindopril)
6 Completed
Has Results
Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome
Condition: Marfan Syndrome
Interventions: Drug: Atenolol;   Drug: Losartan
7 Completed Comparison of Medical Therapies in Marfan Syndrome.
Condition: Marfan Syndrome
Interventions: Drug: Atenolol;   Drug: VERAPAMIL;   Drug: Perindopril
8 Terminated Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome
Condition: Marfan Syndrome
Interventions: Drug: placebo;   Drug: Losartan
9 Completed Losartan Versus Atenolol for the Treatment of Marfan Syndrome
Condition: Marfan Syndrome
Interventions: Drug: Losartan;   Drug: Atenolol
10 Completed Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome--Pediatric Heart Network
Condition: Marfan Syndrome
Interventions: Drug: Losartan Potassium;   Drug: Atenolol
11 Unknown  A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome
Condition: Marfan Syndrome
Interventions: Drug: Losartan and  Atenolol or  Propranolol;   Drug: Atenolol or Propranolol
12 Recruiting Comparison Study of the Effect of Aliskiren Versus Negative Controls on Aortic Stiffness in Patients With Marfan Syndrome Under Treatment With Atenolol
Condition: Marfan Syndrome
Interventions: Drug: Aliskiren;   Drug: Atenolol
13 Recruiting Randomized, Double-blind Study for the Evaluation of the Effect of Losartan Versus Placebo on Aortic Root Dilatation in Patients With Marfan Syndrome Under Treatment With Beta-blockers
Condition: Marfan Syndrome
Interventions: Drug: Losartan;   Drug: Placebo
14 Not yet recruiting Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Conditions: Marfan Syndrome;   Loeys-Dietz Syndrome;   Thoracic Aortic Aneurysm and Dissection Syndromes;   Ehlers-Danlos Type IV Syndrome;   Turner Syndrome
Intervention:
15 Unknown  Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients
Condition: Marfan Syndrome
Interventions: Drug: Losartan and nebivolol;   Drug: Losartan;   Drug: Nebivolol
16 Withdrawn Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome
Condition: Marfan Syndrome
Intervention: Other: Blood draw
17 Recruiting The Oxford Marfan Trial
Condition: Marfan Syndrome
Interventions: Drug: Irbesartan 150-300mg capsules daily for 6 months;   Drug: Doxycycline 100-200mg capsules daily for 6 months;   Drug: Doxycycline placebo capsules daily for 6 months;   Drug: Irbesartan placebo capsules daily for 6 months
18 Recruiting Thoracic Aortic Dilatation Syndromes
Conditions: Thoracic Aorta Dilatation;   Marfan Syndrome
Intervention:
19 Completed Study of Heritable Connective Tissue Disorders
Conditions: Connective Tissue Disease;   Dissecting Aneurysm;   Ehlers Danlos Syndrome;   Marfan Syndrome;   Nail Patella Syndrome
Intervention:
20 Active, not recruiting National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Conditions: Marfan Syndrome;   Turner Syndrome;   Ehlers-Danlos Syndrome;   Loeys-Dietz Syndrome;   FBN1, TGFBR1, TGFBR2, ACTA2 or MYH11 Genetic Mutation;   Bicuspid Aortic Valve Without Known Family History;   Bicuspid Aortic Valve With Family History;   Bicuspid Aortic Valve With Coarctation;   Familial Thoracic Aortic Aneurysm and Dissections;   Shprintzen-Goldberg Syndrome;   Other Aneur/Diss of Thoracic Aorta Not Due to Trauma, <50yo;   Other Congenital Heart Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years